NEMDAA 5

About

Memantine is an N-methyl-D-aspartate (NMDA) receptor antagonist specifically indicated for the treatment of moderate to severe Alzheimer's disease. Its therapeutic action involves blocking the effects of excessive glutamate, an excitatory neurotransmitter that, when overactive, can lead to neuronal dysfunction and cell death in the brains of individuals suffering from Alzheimer's. By modulating glutamatergic neurotransmission, memantine helps to improve various aspects of cognitive function, including memory, attention, and reasoning skills, thereby potentially slowing the symptomatic progression of the disease. It is often utilized as a monotherapy or in combination with cholinesterase inhibitors to provide a more comprehensive approach to managing the complex symptoms of Alzheimer's.

Uses

• Treatment of moderate to severe Alzheimer's disease.
• Improvement of cognitive function.
• Reduction of behavioral symptoms associated with dementia.
• Slowing the progression of Alzheimer's symptoms.

Directions For Use

Take orally once or twice daily, as prescribed by your physician. Dosage may be gradually increased over several weeks.

Benefits

• Improves memory and thinking abilities.
• Enhances daily functional capacity.
• Reduces confusion and agitation.
• Slows cognitive decline in Alzheimer's.
• Well-tolerated in many patients.
• Can be used with other Alzheimer's medications.

Side Effects

• Dizziness
• Headache
• Confusion
• Constipation
• Diarrhea
• Nausea
• Vomiting
• Fatigue
• Hallucinations (rare)
• Hypertension
• Somnolence
• Cough

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can exacerbate dizziness and confusion, and potentially interfere with the medication's effects.
• Pregnancy - Not recommended during pregnancy unless clearly necessary, as animal studies show potential harm; consult a doctor.
• Breastfeeding - It is unknown if memantine passes into breast milk; caution is advised, and a doctor should be consulted.
• Liver - Use with caution in patients with severe hepatic impairment; dosage adjustments may be necessary.
• Kidney - Dosage adjustment is required for patients with moderate to severe renal impairment; close monitoring is essential.
• Lung - No specific contraindications or precautions related to lung conditions are typically associated with memantine.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.